Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

@article{Christopoulos2002AllostericBS,
  title={Allosteric binding sites on cell-surface receptors: novel targets for drug discovery},
  author={Arthur Christopoulos},
  journal={Nature Reviews Drug Discovery},
  year={2002},
  volume={1},
  pages={198-210}
}
  • A. Christopoulos
  • Published 1 March 2002
  • Chemistry, Medicine
  • Nature Reviews Drug Discovery
Cell-surface receptors are the targets for more than 60% of current drugs. Traditionally, optimizing the interaction of lead molecules with the binding site for the endogenous agonist (orthosteric site) has been viewed as the best means of achieving selectivity of action. However, recent developments have highlighted the fact that drugs can interact with binding sites on the receptor molecule that are distinct from the orthosteric site, known as allosteric sites. Allosteric modulators could… Expand
View on Nature
fulltext.calis.edu.cn
574 Citations
Highly Influential Citations
23
Background Citations
202
Methods Citations
9

Figures, Tables, and Topics from this paper

Paper Mentions

Blog Post
More Bacterial Targets Than You Know
In the Pipeline
28 August 2017

574 Citations

Citation Type

Citation Type

Allosteric targeting of receptor tyrosine kinases
TLDR
Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling. Expand
Drugs for allosteric sites on receptors.
TLDR
The presence of druggable, topographically distinct allosteric sites on a wide range of receptor families has offered new paradigms for small molecules to modulate receptor function and key principles and strategies have emerged for the design of ligands/drugs for allosterIC sites. Expand
Allosteric modulators of G-protein-coupled receptors.
TLDR
The current challenge for modulator-based GPCR drug discovery is the optimization of both binding and functional assays to better detect and validate allosteric ligands. Expand
In-Target versus Off-Target allosteric modulators of GPCRs
TLDR
This work highlights the different molecular mechanisms that could be responsible for this phenotype, distinguishing between the commonly assumed In-Target and potential Off-Target modulators. Expand
Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.
TLDR
The current status of putative allosteric agonists of 7TM receptors is reviewed, and the promises and challenges that this class of ligand might pose for pharmacologists and the drug-discovery industry are discussed. Expand
Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
TLDR
This paper presents evidence that orthosteric/allosteric, in other words "dualsteric", hybrid compounds unite subtype selectivity and receptor activation and offers access to GPCR modulators with an unprecedented receptor-subtype and signaling selectivity profile and, as a consequence, to drugs with fewer side effects. Expand
Receptor Targets in Drug Discovery
TLDR
Receptors, located on both the cell surface and within the cell are the defined molecular targets through which drugs produce their beneficial effects in various disease states and can be used in conjunction with high- throughput screening approaches to identify molecules that bind with relatively high affinity to these targets. Expand
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery
TLDR
It is demonstrated that allosteric ligands can cause marked potentiation of previously “inert” metabolic products of neurotransmitters and peptide hormones, a novel consequence of the phenomenon of probe dependence. Expand
for Drug Discovery □ S
TLDR
It is demonstrated that allosteric ligands can cause marked potentiation of previously “inert” metabolic products of neurotransmitters and peptide hormones, a novel consequence of the phenomenon of probe dependence. Expand
Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders
TLDR
Allosteric modulator ligands offer the prospect of engendering a facile stimulus-bias in orthosteric ligand signaling, paving the way for not only receptor-selective but also signaling pathway- selective therapies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 148 REFERENCES
Allosteric binding sites on muscarinic receptors
The classical (acetylcholine) binding sites of all five subtypes of muscarinic receptors are known to be subject to allosteric regulation by a variety of small molecules. The hallmarks of such… Expand
G Protein-Coupled Receptor Allosterism and Complexing
TLDR
It is proposed that the study of allosteric phenomena will become of progressively greater import to the drug discovery process due to the advent of newer and more sensitive GPCR screening technologies. Expand
Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site
  • F. Knoflach, V. Mutel, +5 authors J. Kemp
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2001
TLDR
Two chemical series of compounds acting as selective positive allosteric modulators of native and recombinant metabotropic glutamate 1 (mGlu1) receptors were identified, markedly potentiated agonist-stimulated responses, increasing potency and maximum efficacy. Expand
Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation.
  • D. Hall
  • Chemistry, Medicine
  • Molecular pharmacology
  • 2000
TLDR
A mathematical model of allosteric interactions at pharmacological receptors has been investigated and used to provide a potential mechanistic explanation for the functional effects of the A(1) adenosine receptor allosterIC enhancer PD 81,723 and a recently reported allosterics modulator of type 1 metabotropic glutamate receptors. Expand
Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
  • F. Ehlert
  • Chemistry, Medicine
  • Molecular pharmacology
  • 1988
TLDR
The theoretical basis for using radioligand binding and pharmacological techniques to estimate the dissociation constants of drugs which interact allosterically with receptors is described and the effect of changes in affinity and intrinsic efficacy of the agonist-receptor complex is predicted. Expand
Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.
  • T. Costa, A. Herz
  • Chemistry, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1989
TLDR
It is shown that for a member of this family of receptors (delta opioid receptors in membranes of NG108-15 neuroblastoma-glioma cells), two types of competitive antagonists can be distinguished and one has no intrinsic activity and the second can inhibit GTPase and thus exhibits negative intrinsic activity. Expand
Structural and functional aspects of G protein-coupled receptor oligomerization.
TLDR
Evidence is reviewed that receptor oligomerization and in particular dimerization may play an important role in the molecular events leading to GPCR activation, and biochemical and functional evidence supporting this notion is reviewed. Expand
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
  • T. Kenakin
  • Biology, Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2001
TLDR
Evidence for the existence of the various types of agonism and the potential therapeutic utility of differ¬ent agonist types is reviewed. Expand
A Pharmacologic Analysis of Drug-Receptor Interaction
Drug receptor/theory seven transmembrane receptor behaviour human recombinant receptor systems stimulus-response mechanisms drug response mechanisms diffusion and drug concentration in receptor… Expand
Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
In an attempt to locate the allosteric site on muscarinic receptors to which gallamine binds, 21 residues in the putative external loops and loop/transmembrane helix interfaces have been mutated to… Expand
...
1
2
3
4
5
...